RayKnowChina Research Map
Shortlist

Other diseases

Wilson disease

肝豆状核变性(Wilson 病)

A rare inherited disease, passed on when both parents carry a changed ATP7B gene, in which copper builds up in the brain, liver, cornea and other organs, leading to progressive liver and nervous-system problems.

Definition adapted from MeSH (US National Library of Medicine)

Listed in China's first national rare-disease catalogue (2018, no. 37). National Health Commission 国卫医发〔2018〕10号

hospitals in mainland China
28

with a paper from 2016–2025 or a registered study

cities
17

where those hospitals are

open trials in China
8

ClinicalTrials.gov, 8 Nov 2026

Mainland China accounts for 34% of the world's English-language research papers on Wilson disease, 2021–2025 (16% in 2016–2020), and 19% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

28 hospitals in 17 cities

Order: papers led on Wilson disease, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 2 papers or 1 trial on Wilson disease, or was a site in 2 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Guangzhou5
  2. Hefei4
  3. Beijing3
  4. Hangzhou3
  5. Changchun1
  6. Changsha1
  7. Chengdu1
  8. Fuzhou1
  9. Jinan1
  10. Nanchang1

Each opens Wilson disease in that city. 7 more cities are in the menu below.

  1. 52 papers led
    No open trial led
  2. 8 papers led
  3. Second Xiangya Hospital

    中南大学湘雅二医院Changsha

    7 papers led
    No open trial led
  4. 6 papers led
    No open trial led
  5. First Affiliated Hospital of USTC

    中国科学技术大学附属第一医院(安徽省立医院)Hefei

    6 papers led
    No open trial led
  6. Beijing Youan Hospital, Capital Medical University

    首都医科大学附属北京佑安医院Beijing

    5 papers led
    No open trial led
  7. Fourth Hospital of Sichuan University

    四川大学华西医学中心Chengdu

    5 papers led
    No open trial led
  8. Affiliated Hospital, Anhui University of Chinese Medicine

    安徽中医药大学神经病学研究所附属医院Hefei

    4 papers led
    No open trial led
  9. 4 papers led
  10. First Affiliated Hospital, Zhejiang University

    浙江大学医学院附属第一医院Hangzhou

    4 papers led
  11. Beijing Tongren Hospital

    首都医科大学附属北京同仁医院Beijing

    3 papers led
    No open trial led
  12. 3 papers led
  13. 3 papers led
    No open trial led
  14. 3 papers led
    No open trial led
  15. 2 papers led
    No open trial led
  16. 2 papers led
    No open trial led
  17. 2 papers led
    No open trial led
  18. 2 papers led
    No open trial led
  19. 2 papers led
    No open trial led
  20. 2 papers led
    No open trial led
  21. 2 papers led
    No open trial led
  22. 2 papers led
    No open trial led
  23. Shengjing Hospital of China Medical University

    中国医科大学附属盛京医院Shenyang

    2 papers led
    No open trial led
  24. Xinhua Hospital

    上海交通大学医学院附属新华医院Shanghai

    2 papers led
    No open trial led
  25. 1 paper led
    No open trial led
  26. 1 paper led
    No open trial led
  27. 1 paper led
    No open trial led
  28. 0 papers led
    No open trial led

By university or health system 21

Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.

  1. Capital Medical University

    首都医科大学Beijing

    15 papers led
    6 hospitals
  2. Zhejiang University School of Medicine

    浙江大学医学院Hangzhou

    13 papers led
    4 hospitals
  3. Central South University (Xiangya)

    中南大学湘雅Changsha

    7 papers led
    1 hospital
  4. Sun Yat-sen University

    中山大学Guangzhou

    7 papers led
    2 hospitals
  5. 7 papers led
    1 hospital
  6. Guangdong Pharmaceutical University

    广东药科大学Guangzhou

    6 papers led
    4 hospitals
  7. Sichuan University (West China)

    四川大学华西Chengdu

    6 papers led
    1 hospital
  8. Fujian Medical University

    福建医科大学Fuzhou

    4 papers led
    1 hospital
  9. Shanghai Jiao Tong University School of Medicine

    上海交通大学医学院Shanghai

    4 papers led
    3 hospitals
  10. China Medical University (Shenyang)

    中国医科大学Shenyang

    3 papers led
    2 hospitals
  11. Nanjing Medical University

    南京医科大学Nanjing

    3 papers led
    4 hospitals
  12. Shenzhen University

    深圳大学Shenzhen

    3 papers led
    1 hospital
  13. Guangzhou Medical University

    广州医科大学Guangzhou

    2 papers led
    1 hospital
  14. Jilin University

    吉林大学Changchun

    2 papers led
    1 hospital
  15. Jinan University

    暨南大学Guangzhou

    2 papers led
    1 hospital
  16. Qingdao University

    青岛大学Qingdao

    2 papers led
    1 hospital
  17. Shandong First Medical University

    山东第一医科大学Jinan

    2 papers led
    1 hospital
  18. Soochow University

    苏州大学Suzhou

    2 papers led
    1 hospital
  19. Anhui Medical University

    安徽医科大学Hefei

    1 paper led
    1 hospital
  20. Fudan University

    复旦大学Shanghai

    1 paper led
    1 hospital
  21. Zhengzhou University

    郑州大学Zhengzhou

    1 paper led
    1 hospital

8

open trials on Wilson disease in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with at least one listed hospital as lead sponsor or site. 5 of them are led by a listed hospital. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

What the phases mean (US National Cancer Institute)

  1. Recruiting
    Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
    Phase
    Phase 3
    Started
    2026-09
    Registry
    NCT07465718

    Age 8 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Hangzhou

  2. Recruiting
    A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
    Phase
    Early phase 1
    Started
    2025-12
    Registry
    NCT07240896

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHefei

  3. Recruiting
    A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
    Phase
    Early phase 1
    Started
    2024-09
    Registry
    NCT06650319

    Age 10 years to 60 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  4. Recruiting
    A Registered Cohort Study on Wilson's Disease
    Phase
    Not given
    Started
    2019-07
    Registry
    NCT04012658

    Age not stated (registered criteria)

    Led by First Affiliated Hospital of Fujian Medical UniversityFuzhou

  5. Recruiting
    China Registry for Genetic / Metabolic Liver Diseases
    Phase
    Not given
    Started
    2015-06
    Registry
    NCT03131427

    Age not stated (registered criteria)

    Led by Beijing Friendship Hospital; 1 listed hospital as study siteBeijing

  6. Recruiting
    Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
    Phase
    Not given
    Started
    2004-01
    Registry
    NCT04965545

    Age 6 years to 65 years (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  7. Recruiting
    Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease
    Phase
    Not given
    Started
    2004-01
    Registry
    NCT04965558

    Age 6 years to 65 years (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  8. Not yet recruiting
    Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease
    Phase
    Phase 1/Phase 2
    Started
    2026-06
    Registry
    NCT07641140

    Age 18 years to 60 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Before contacting a hospital

The same for every disease, so it is kept on one page. Each hospital page also has an enquiry letter in English and Chinese, and a name card to show staff.

Where these numbers come from

Papers

201 English-language PubMed papers on Wilson disease with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 8 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions